Skip to content
Cryptos: 564Market Cap: $2.82T 0.1%24h Vol: $117.94BDominance: BTC 58.0% ETH 10.4%
Open Tradzy

New high · Denmark stocks

Novozymes A/S (NSIS-B) closes at a 52-week high of DKK 466.60

Up 6.7% over 20 sessions. The previous highest close was DKK 463.00 on 20 Oct 2026.

Published 21 October 2026 · Written from Tradzy's price and volume data

Close
DKK 466.60
On the day
+0.8%
Volume
0.8× average
vs 52-week high
New high

Novozymes A/S closing prices

DKK 400.00DKK 425.00DKK 450.00Jun '26Jul '26Aug '26Sep '26Sep '26Oct '26DKK 466.60

The last 90 closes up to 21 October 2026. The live chart is on the NSIS-B page.

What happened

Novozymes A/S (NSIS-B) closed at DKK 466.60 on 21 October 2026, up 0.8% from DKK 463.00 the session before.

It was the third higher close in a row. Over 5 sessions the price is up 3.9%, and over 20 sessions it is up 6.7%.

That close is above every close of the past year. The previous highest was DKK 463.00 on 20 Oct 2026, and the new close is 0.8% above it.

Volume was close to its recent average.

Across the 11 COPENHAGEN stocks we track, 4 closed higher and 5 closed lower that day, with a median change of 0.00%. NSIS-B's change was +0.8%.

This page reports what the price and volume data show. It does not say why the price moved.

The numbers

Previous closeDKK 463.00
CloseDKK 466.60
Change on the day+0.78%
Change over 5 sessions+3.92%
Change over 20 sessions+6.68%
Volume540,858
Average volume, up to 20 sessions before673,312
Volume against that average0.8 times
Highest close in the past yearDKK 463.00 (20 Oct 2026)
Lowest close in the past yearDKK 342.00 (19 Mar 2026)

The full chart and history are on Novozymes A/S (NSIS-B). More from this market: COPENHAGEN news today.

More COPENHAGEN moves on 21 October 2026

Want a plan for NSIS-B? Open it in Tradzy: the Analyst Engine reads the chart and lays out an entry, a stop and targets, and you can practise the trade with paper money first.

Open Tradzy

Built from Tradzy's own price and volume data. It reports what the market did and does not say why. Nothing here is financial advice. See the disclaimer.